MedTrace Logo

Juvista (Avotermin) in Scars Following Varicose Vein Removal

NCT00430326 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 156

Last updated 2010-03-09

No results posted yet for this study

Summary

This trial is being undertaken to investigate the efficacy and safety of Juvista in the improvement of scar appearance when administered to approximated wound margins following varicose vein surgery. The results from this trial will be used to select doses for investigation in future clinical trials with the compound.

Conditions

  • Varicose Veins
  • Cicatrix

Interventions

DRUG

Avotermin

Sponsors & Collaborators

  • ICON Clinical Research

    collaborator INDUSTRY

  • Renovo

    lead INDUSTRY

Principal Investigators

  • Peter McCollum, MB MCh FRCS · Hull Royal Infirmary

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2009-01-31
Completion
2009-04-30

Countries

  • Belgium
  • Latvia
  • Lithuania
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00430326 on ClinicalTrials.gov